JFL Life Sciences Ltd Financials
Company Logo

JFL Life Sciences Ltd Financial Statement

JFL Life Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

JFL Life Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual46.55
Operating Expenses Annual42.00
Operating Profit Annual5.07
Interest Annual0.83
Depreciation0.44
Net Profit Annual3.31
Tax Annual0.49

JFL Life Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.06
Cash Flow from Operations8.36
Cash Flow from Investing-6.07
Cash Flow from Financing-2.31
Cash Flow at the End0.03

JFL Life Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)10.89
PBIT Margin (%)9.95
PBT Margin (%)-2.04
Net PROFIT Margin (%)7.11
Return On Networth / Equity (%)9.76
Return On Networth /Employed (%)11.44
Return On Assets (%)8.18
Total Debt / Equity (X)0.19
Asset Turnover Ratio (%)1.15

JFL Life Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual12.47
Total Current Assets Annual43.13
Non Current Assets Annual13.51
Total Shareholders Funds Annual35.58
Total Assets Annual56.64

JFL Life Sciences Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, JFL Life Sciences Ltd has a market capitalization of 43.28 Cr. Value Research classifies it as a Micro-Cap company.
Yes, JFL Life Sciences Ltd is debt-free with a debt-to-equity ratio of 0.16.
In FY 2023 , JFL Life Sciences Ltd recorded a total revenue of approximately 46.55 Cr marking a significant milestone in the company's financial performance.
JFL Life Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..
JFL Life Sciences Ltd's current PE ratio is 13.08.
JFL Life Sciences Ltd's ROCE averaged 15.3% from the FY ending March 2022 to 2024, with a median of 13.0%. It peaked at 21.7% in March 2022, reflecting strong capital efficiency over the period..
JFL Life Sciences Ltd's latest EBIT is Rs. 4.64 Cr, surpassing the average EBIT of Rs. 5.22 Cr over the 5 years..